🟢 Cue Biopharma is trading 5.6% up in after-hours trading; catalyst remains unconfirmed

Cue Biopharma is trading at $29.82, up +5.61%, while the catalyst remains unconfirmed.

• Gained 8.20% during the August 11 regular session before extending higher after the close.
• No verified August 11 company-specific announcement or late-breaking catalyst was identified; the latest investor-relations release remains the August 3 CFO appointment and CUE-221 investigational new drug submission announcement.
• Broader markets were weaker, so macro sentiment does not clearly explain the move.